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Conjugated linoleic acids (CLA) are positional and geometric isomers of linoleic acid involved in a number of health aspects.
In humans, CLA production is performed by gut microbiota, including some species of potential probiotic bifidobacteria. 128
strains of 31 Bifidobacterium species were screened with a spectrophotometric assay to identify novel CLA producers. Most species
were nonproducers, while producers belonged to B. breve and B. pseudocatenulatum. GC-MS revealed that CLA producer strains
yielded 9cis,11trans-CLA and 9trans,11trans-CLA, without any production of other isomers. Hydroxylated forms of LA were absent
in producer strains, suggesting that themyosin-cross-reactive antigen (MCRA) protein that exerts hydratase activity is not involved
in LA isomerization. Moreover, both CLA producer and nonproducer species bear a MCRA homologue. The strain B. breve WC
0421 was the best CLA producer, converting LA into 68.8% 9cis,11trans-CLA and 25.1% 9trans,11trans-CLA. Production occurred
mostly during the lag and the exponential phase. For the first time, production and incorporation of CLA in biomass were assessed.
B. breveWC 0421 stored CLA in the form of free fatty acids, without changing the composition of the esterified fatty acids, which
mainly occurred in the plasmatic membrane.
1. Introduction
Conjugated linoleic acids (CLA) are a group of positional
and geometric isomers of linoleic acid (LA, cis9, cis12-C18:2)
that have conjugated double bonds. Diverse CLA isomers
have been identified with different position (ranging from
Δ7, Δ9 to Δ12, Δ14) and cis/trans geometry. 9cis,11trans-CLA
and 10trans,12cis-CLA are the major isomers occurring in
human diet, the former being contained mostly in ruminant
meat and dairy products and the latter in hydrogenated oils.
Considerable research has been directed toward understand-
ing the production and the physiological effects of CLA and
there is increasing evidence of their involvement in a number
of health aspects. Potential health-promoting properties of
CLA include anticarcinogenesis, antiatherosclerosis, antidi-
abetes, antiobesity, antiallergy activities, and enhancement of
immune functions [1].
CLA are intermediates of the biohydrogenation of linoleic
acid (LA) and unsaturated fatty acids, a microbial process by
which the fatty acids released by lipolytic enzymes undergo
the progressive saturation. Microbial isomerization of LA
into CLA was firstly described in the gut of ruminants, but
diverse isolates from human feces have been demonstrated to
take part in LA biohydrogenation, indicating that production
of CLA and 11trans-C18:1 (vaccenic acid) occurs in the human
gut as well [2–5]. In fact, humans excrete some linoleic acid
(LA) with feces [6], suggesting that this substrate is available
for microbial production of CLA within the colon. Several
colonic species belonging to Cluster IV, Cluster XIVa, and
Bifidobacterium genus are involved in LA transformation
toward CLA, including 9cis,11trans-CLA and vaccenic acid.
Some species of bifidobacteria, natural colonizers of the
gut, are capable to transform LA into 9cis,11trans-CLA and
into lower amounts of 9trans,11trans-CLA and 10trans,12cis-
CLA. Previous studies suggested that the MCRA protein
of bifidobacteria may be involved in isomerization of LA
to CLA, through hydration of unsaturated fatty acids, for
example, converting palmitoleic, oleic, and linoleic acids to
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the corresponding 10-hydroxy fatty acids [7, 8]. However,
more recent evidences excluded the role of bifidobacterial
MCRA in CLA production [9].
The ability of various bifidobacteria to produce
9cis,11trans-CLA raised the question as to whether CLA
production may be regarded as one of the mechanisms by
which bifidobacteria exert some of their beneficial properties
[10]. In fact, it is known that commensal bifidobacteria exert
a number of beneficial health effects through a variety of
different mechanisms.
For this reason, they are increasingly being used in
functional foods and pharmaceutical products and are gen-
erally regarded as probiotics [11–13].The present study aimed
to identify novel CLA producers among a wide range of
Bifidobacterium species and strains and to explore unedited
aspects of CLA accumulation, such as the effect of LA and
CLA in microbial lipid composition and the accumulation
of hydroxylated forms of linoleic acid, ascribable to MCRA
activity.
2. Materials and Methods
2.1. Chemicals, Strains, and Culture Conditions. All chem-
icals were purchased from Sigma Aldrich (Steinheim Ger-
many) unless otherwise stated. 128 strains of Bifidobac-
terium (Table 1) were obtained from ATCC or from our
culture collection (WC-labeled strains). Bifidobacteria were
cultured in lactobacilli deMan-Rogosa-Sharpe broth (Becton
Dickinson, Franklin Lakes, NJ, USA) supplemented with
0.5 g/L L-cysteine⋅HCl (hereinafter called MRS), at 37∘C in
an anaerobic cabinet (Forma Scientific, Marietta, OH, USA)
under N
2
85%, CO
2
10%, and H
2
5% atmosphere.
The analysis of the biotransformation of linoleic acid
(LA) into conjugated linoleic acid (CLA) was carried out
in MRS broth supplemented with 0.5 g/L LA (hereinafter
calledMRS-LA). A solution of 40mg/mL LA in 20 g/L Tween
80 was prepared, filter sterilized (cellulose acetate, 0.22𝜇m;
Millipore, Billerica, MA, USA), and added to the sterile MRS
in proper amount to obtain 0.5 g/L LA. Bifidobacteria from
16 h MRS cultures were inoculated (10% v/v) into MRS-LA
and incubated at 37∘C for 48 h.
2.2. Kinetic of CLA Production and Bioreactor Operation.
Controlled-pH batch cultures were carried out in laboratory-
scale fermenters (Sixfors, Infors, Bottmingen, Switzerland)
with 500mL of MRS or MRS-LA medium. The bioreactor
was inoculated with 50mL of a 24 h seed culture grown
in MRS or MRS-LA medium, respectively. To investigate
CLA production during stationary phase, LA was added to
MRS cultures after 24 h of growth. Temperature was kept at
37∘C, stirring at 200 rpm, and pH was maintained constant
at 5.5 through the automatic addition of 4M NaOH. The
bioreactor was kept under nitrogen overpressure to main-
tain anaerobiosis conditions. The culture was periodically
sampled to monitor bacterial growth, glucose consumption,
and the concentration of LA and CLA in the broth. The
biomass/substrate yield (𝑌X/S) was expressed as g of dry
biomass g−1 consumed glucose. During the mid-exponential
growth phase and at the entrance of the stationary phase,
Table 1: Bifidobacterium strains screened for CLA production,
by measuring the absorbance of conjugate diene (𝐴
233
) after 24 h
growth in MRS-LA. ∗ indicates species bearing a gene homologue
to MCRA from B. breve NCIMB 702258. The 34 strains that were
selected for GC quantification of CLA and PCR amplification are
underscored.
Species Strains
B. adolescentis∗ ATCC 15703, WC 9806
B. angulatum∗ ATCC 27535
B. animalis subsp. animalis∗ ATCC 25527, WC 0409, WC 9343
WC 0410
B. animalis subsp. lactis∗
ATCC 27536, WC 0411, WC 0412,
WC 0413, WC 0414, WC 0432,
WC 0455, WC 0459, WC 0460,
WC 0469, WC 0471
B. asteroides ATCC 25910
B. bifidum∗ WC 0415, WC 0417, WC 0418
B. boum ATCC 27917
B. breve∗
WC 0420, WC 0421, WC 0422,
WC 0423, WC 0424, WC 9436,
WC 9437, WC 9445, WC 9445,
WC 9446, WC 9449, WC 9491,
WC 9492, WC 9493, WC 9495,
WC 9498, WC 9499, WC 9500,
WC 9501, WC 9504, WC 9505,
WC 9508
B. catenulatum∗ ATCC 27539, WC 0458, WC 0467
B. choerinum ATCC 27686
B. coryneforme ATCC 25911
B. cuniculi ATCC 27916
B. dentium∗ ATCC 27534
B. gallicum ATCC 49850
B. gallinarum ATCC 33777
B. indicum ATCC 25912
B. longum subsp. infantis∗ ATCC 15697, WC 0433,
WC 0434
B. longum subsp. longum∗
ATCC 15707, WC 0435, WC 0436,
WC 0437, WC 0438, WC 0439,
WC 0440, WC 0441, WC 0442,
WC 0443, WC 0444, WC 0473,
WC 9711, WC 9712, WC 9717,
WC 9718, WC 9721, WC 9722,
WC 9724, WC 9741, WC 9742,
WC 9743, WC 9745, WC 9746,
WC 9747, WC 9748, WC 9749,
WC 9751, WC 9752, WC 9753,
WC 9754, WC 9756, WC 9757,
WC 9758, WC 9759, WC 9760,
WC 9761, WC 9762, WC 9763,
WC 9765, WC 9766, WC 9767,
WC 9768, WC 9769, WC 9770,
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Table 1: Continued.
Species Strains
WC 9772, WC 9773
B. longum subsp. suis ATCC 27533
B. magnum ATCC 27540
B. merycicum ATCC 49391
B. minimum ATCC 27538
B. pullorum ATCC 27685
B. pseudocatenulatum∗
ATCC 27919, WC 0400, WC 0401,
WC 0402, WC 0403, WC 0404,
WC 0405, WC 0407, WC 0408,
WC 9359
B. pseudolongum∗ ATCC 25526
B. psychraerophilum NCIMB 13940
B. ruminantium ATCC 49390
B. saeculare ATCC 49392
B. scardovii∗ ATCC BAA-773
B. subtile ATCC 27683
B. thermophilum∗ ATCC 25525
200mL of the culture were collected in order to separate the
biomass and perform on it the analysis of lipid fraction.
2.3. Spectrophotometric Analysis of CLA in the Supernatant.
In order to screen all the bifidobacteria for the capability to
produce CLA, a rapid spectrophotometric method was used,
based onUVabsorption of conjugated double bonds [14].The
culture sample was centrifuged (13,000×g for 5min at 4∘C)
and 1mL of supernatant wasmixed with 2mL of isopropanol.
After the addition of 1.5mL of hexane, the sample was
thoroughly vortexed in order to extract the lipids and then
allowed to stand 5min. The hexane layer was collected and
the absorbance was measured at 233 nm (𝐴
233
).
2.4. Extraction of Lipids and Preparation of Fatty Acyl-Methyl-
Esters. To extract cell-associated lipids, the biomass of
200mL of culture was harvested by centrifugation (9,000×g
for 10min at 4∘C), washed with water, frozen at −80∘C,
and lyophilized (Heto Lyolab 3000, Allerød, Denmark).
Lyophilized biomass was mixed (2% w/v) with a 2 : 1 (v/v)
chloroform :methanol solution and shaken at r.t. for 16 h.The
extract was filtered through celite and anhydrous Na
2
SO
4
,
solvents were removed using a rotavapor apparatus, and
lipids were weighed. To determine the amount of LA and
CLA in the supernatant, 3mL was thoroughly vortexed with
3mL of ethyl acetate. The organic phase was separated and
anhydrified; then the solvent was removed.
The free fatty acids (FFAs) and the esterified fatty acids
(EFAs), such as glycerides and phospholipids, were trans-
formed into the corresponding methyl-esters (FAMEs) to be
analyzed by GC-MS. The FFAs contained in the lipid extract
of the biomass or the supernatant were methylated through
diazomethane reaction [15]. The extract was dissolved in
the ethyl ether solution of diazomethane, freshly prepared
from Diazald, and incubated at r.t. for 10min. Once the
solvent had evaporated, FAMEs were dissolved in 1mL of
ethyl acetate containing 0.5mg/mL methyl undecanoate as
internal standard and analyzed.
The EFAs contained in the lipid extract of the biomass
were transesterified through alkali-catalyzed reaction [16].
The lipid extract was dissolved in 2mL of ethyl ether con-
taining 1mg/mL triundecanoin as internal standard. 50 𝜇L of
3.3M sodium methoxide (methanol solution) was added to
the reaction mixture and the sample was homogenized. After
10min incubation at r.t., the reaction was stopped with 30 𝜇L
of acetic acid.
2.5. GC-MS Analysis. The organic phases containing FAMEs
were injected (0.5 𝜇L) into a GC apparatus (HP5890 Series
II, Agilent,Waldbronn, Germany) equipped with the column
(100m × 0.25mm, 0.25 𝜇m) CP-Select FAME (Varian, Palo
Alto, CA, USA).The injector was kept at 270∘C. To determine
the whole profile of FAs, the oven temperature ramped from
135∘C to 250∘C (2.5∘C/min) and was maintained at 250∘C
for 23min. The same program was followed, starting from
160∘C, when only LA and CLA had to be determined. Elu-
tion was performed with high-purity helium, with constant
column head pressure of 200 kPa. Qualitative analyses of
FAMEs were performed with a MS quadrupole detector
(HP5972, Agilent). Analytes were identified by comparison
with standards (O5632, Sigma Aldrich) and by analysis
of their fragmentation patterns (EI, 70 eV) with the mass
spectrum library NIST 2005 (Gatesburg, USA). Quantitative
analyses were performed with a flame ionization detector
held at 300∘C.
2.6. Alignment Analysis of Putative Bifidobacterium MCRA
Genes and PCR Amplification. In order to verify the presence
of homologues of MCRA from B. breve NCIMB 702258
(Protein ID ADY18551.1) a search was performed among all
the species of Bifidobacterium, using the tblastn program
provided by the National Center of Biotechnology Informa-
tion (http://www.ncbi.nlm.nih.gov/).The available sequences
of putative MCRA gene of Bifidobacterium spp. were
aligned using the Clustal omega program (http://www.ebi.ac
.uk/). To amplify the conserved region of MCRA genes,
the primers MCRAf (5󸀠-GCGGSCGCGARATGGACAA-3󸀠)
and MCRAr (5󸀠-CCGCCGTTGGTGATGAACAC-3󸀠) were
designed. These primers anneal with the gene sequence of
B. breve NCIMB 702258 (GenBank accession HQ593838H)
at positions 236–255 and 958–978 and generate amplicons
of 742 bp. Amplification was performed with the following
program: 4min at 94∘C; 30 cycles of 30 s at 94∘C; 30 s at 58∘C;
1min at 72∘C; 1min at 72∘C.
2.7. Statistical Analysis. All values are described by themeans
and the standard deviation of three separate experiments.
Comparisons were performed with one-way ANOVA fol-
lowed by Tukey post hoc comparisons. Differences were
considered statistically significant for 𝑃 < 0.05. Statistical
analysis was done using GraphPad Prism 4.0 (GraphPad
Software, San Diego, CA, USA).
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3. Results
3.1. Spectrophotometric Screening of Conjugated Linoleic Acid
Production. 127 Bifidobacterium strains belonging to 31 dif-
ferent species or subspecies (Table 1) were cultured in MRS-
LA medium, containing 0.5 g/L of free LA. With the excep-
tion of 3 strains belonging to the species B. coryneforme,
B. gallinarum, and B. saeculare, unable to grow in presence
of LA, all bifidobacteria grew in MRS-LA achieving OD
600
ranging between 1.1 and 5.7 after 24 h (data not shown).
To obtain a preliminary estimation of CLA production,
the supernatant of 24 h cultures in MRS-LA was extracted,
and the UV absorbance by conjugated double bonds was
measured at 𝜆 = 233 nm (𝐴
233
). 𝐴
233
ranged between 0 and
2.37 a.u., with the vast majority of the strains (>75%) yielding
an extract with absorbance lower than 0.5 a.u.With the aim to
validate the spectrophotometric assay, total CLA were quan-
tified by GC-MS in the supernatant of 34 strains belonging
to the species B. animalis subsp. lactis, B. bifidum, B. breve,
B. catenulatum, B. longum subsp. infantis, B. longum subsp.
longum, and B. pseudocatenulatum, covering the whole 𝐴
233
range. The dot dispersion of 𝐴
233
against CLA production
revealed that CLA production can be excluded for𝐴
233
< 0.5
(Figure 1(a)). Above this value, higher absorbance roughly
corresponded to higher CLA concentration, although a direct
relationship could not be established (𝑅2 = 0.87).
All the strains belonging to the species B. adolescentis,
B. angulatum, B. bifidum, B. boum, B. choerinum, B. cuni-
culi, B. dentium, B. gallicum, B. indicum, B. magnum, B.
merycicum, B. minimum, B. pullorum, B. pseudolongum, B.
psychraerophylum, B. ruminantium, B. scardovii, B. subtile,
and B. thermophilum and most of the strains belonging to B.
animalis subsp. animalis, B. animalis subsp. lactis, B. longum
subsp. infantis, B. longum subsp. longum, and B. longum
subsp. suis fell into the group of CLA producers (Figure 1(b)).
The species B. breve and the group of B. catenulatum and
B. pseudocatenulatum were the highest CLA producers, even
though wide variability was observed.The extracts of B. breve
presented the highest𝐴
233
(mean = 1.08, median = 0.73), fol-
lowed by those of B. catenulatum and B. pseudocatenulatum
(mean = 0.62,median = 0.45). All the strains with𝐴
233
higher
than the 90th percentile belonged to the species B. breve and
B. pseudocatenulatum (Figure 1(b)). In particular, one strain
of B. pseudocatenulatum and five of B. breve presented 𝐴
233
higher than 2.0 a.u. andwere selected for deeper investigation
of CLA production.
3.2. Search of MCRA Gene in Bifidobacterium Species. A
tblastn search was performed for all the species of Bifidobac-
terium reported in Table 1, in order to verify the presence
of a homologue of MCRA from B. breve NCIMB 702258
(Protein ID ADY18551.1). Of the 31 species, 14 bear a gene
encoding a protein with sequence identity from 55 to 94%:
B. adolescentis, B. angulatum, B. animalis subsp. animalis, B.
animalis subsp. lactis, B. bifidum, B. breve, B. catenulatum, B.
dentium, B. longum subsp. infantis, B. longum subsp. longum,
B. pseudocatenulatum, B. pseudolongum, B. scardovii, and B.
thermophilum. All the 34 strains that were selected for the GC
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Figure 1: UV absorbance (𝐴
233
) of the lipophilic extracts that
were obtained from the supernatants of 24 h MRS-LA cultures
of bifidobacteria. (a) Relationship between 𝐴
233
and total CLA
concentration in the supernatant in a selection of 34 strains. (b)
Screening of 127 Bifidobacterium strains. Boxes represent the range
between 25th and 75th percentiles and the line inside represents
the median. Whiskers denote the range between 10th and 90th
percentiles and asterisks represent outlier values. Strains numbers
are in brackets.
quantification of CLA were positive to MCRA-targeted PCR,
yielding an amplicon of approx. 750 bp (Table 1).
3.3. CLA Production by Selected Strains. Yields and the
composition of CLA were determined in the supernatants
of B. breve WC 0420, B. pseudocatenulatum WC 0403, B.
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Table 2: Residual LA (%) and conversion yield into 9cis,11trans-CLA, 9trans,11trans-CLA, and total CLA (%) by bifidobacteria cultured for
48 h in MRS-LA medium.
LA 9cis,11trans-CLA 9trans,11trans-CLA Total CLA
B. breveWC 0420 86.8a 13.2a 0.0a 13.2a
B. pseudocatenulatumWC 0403 81.5a 14.3a 4.2b 18.5b
B. breveWC 0422 58.2b 37.2b 4.7b 41.8c
B. breveWC 0424 22.7c 70.2c 7.0c 77.3d
B. breveWC 0423 12.4d 80.3d 7.3c 87.6e
B. breveWC 0421 11.9d 81.1d 7.0c 88.1e
Values are means, 𝑛 = 3; SD always < 5%. Means in a column with different superscripts significantly differ (𝑃 < 0.05).
breve WC 0422, B. breve WC 0424, B. breve WC 0423, and
B. breveWC 0421, after 48 h of growth in MRS-LA (Table 2).
Conversion of LA intoCLA ranged between 13.2 and 88.1%.B.
breveWC 0421 and B. breveWC 0423 were the most efficient
CLA producers, with yields of 88.1 and 87.6%, respectively.
9cis,11trans-CLA and 9trans,11trans-CLA were the sole CLA
isomers occurring in supernatants.The former was themajor
product of LA isomerization, accounting for 13.2 to 81.1% of
LA conversion and for 77 to 100% of total CLA isomers. The
latter was generally found in lower amount, never exceeding
the 7.3% of LA conversion and the 23% of total CLA. The
ratio 9cis,11trans-CLA : 9trans,11trans-CLA ranged between
3.4 and 11.6 and increased augmenting the total amount of
CLA produced. None of these strains produced hydroxylated
forms of LA.
3.4. Kinetic of LA Isomerization into CLA by B. breveWC0421.
Constant-pH batch cultures of B. breveWC0421 were carried
out in MRS and MRS-LA. The presence of 0.5 g/L LA caused
an extension of the lag-phase of approx. 6 h, slowed down the
specific growth rate (0.33 and 0.11 h−1 in MRS and MRS-LA,
resp.), and delayed the entrance into stationary phase of 2 h.
Thebiomass/glucose yieldwas lower inMRS-LA than inMRS
(8 and 13%, resp.), whereas the percentage lipid/biomass was
higher in the medium containing LA (7.5% and 2.5%, resp.).
The isomerization of LA into CLA occurred mostly during
the lag and the exponential phases (Figure 2). After 24 hof fer-
mentation, during the exponential phase, the transformation
of LA resulted in the production of 9cis,11trans-CLA (83.6%)
and, at a minor extent, of trans9,trans11-CLA (4.5%). During
the late exponential and stationary phases, LA isomeriza-
tion proceeded slowly and 9trans,11trans-CLA progressively
accumulated at the expenses of 9cis,11trans-CLA. Altogether,
the conversion yield of LA into CLA was 94.3% after 52 h.
In particular, conversion yields into 9cis,11trans-CLA and
9trans,11trans-CLA were 68.8 and 25.1%, respectively. All
other CLA isomers were always negligible throughout the
fermentation.
When 0.5 g/L LA was added to MRS cultures at
the entrance into the stationary phase, the isomerization
occurred at minor extent, resulting in production of the sole
9cis,11trans-CLA isomer with a conversion of 6.1% after 48 h
incubation.
3.5. Lipid Composition of the Biomass. The profile of free and
esterified fatty acids (FFA and EFA) within the lipid fraction
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Figure 2: Time-course of growth and CLA production by B. breve
WC 0421 in MRS medium containing 0.5 g/L LA. ⃝: turbidity
(OD
600
), 󳵻: LA (%), 󳵳: 9cis,11trans-CLA (%), and e: trans9,trans11-
CLA (%). The results are representative of the three independent
experiments.
of B. breve WC 0421 biomass was investigated (Table 3).
In MRS, lipids were dominated by EFA (ca 93% of total
lipids), while FFA were found in low amounts (≤8%). At the
exponential and stationary phases, oleic acid was the most
abundant among both EFA and FFA, occurring formore than
40%. Palmitic and myristic acids and palmitic and stearic
acids represented the other major fatty acids among EFA and
FFA, respectively.
During the cultivation in MRS-LA, B. breve WC 0421
accumulated a high amount of FFA, which accounted for ca
75% of total lipids at the stationary phase. LA occurred in low
amount (<4%) among both EFA and FFA. 9cis,11trans-CLA
dominated the profile of FFA, always accounting for more
than 56%. The composition of EFA was similar in MRS and
MRS-LA.
The supplementation of 0.5 g/L LA at the entrance into
the stationary phase did not cause accumulation of relevant
amounts of CLAas free or esterified fatty acid in themicrobial
biomass. 24 h after LA addition, EFA composition remained
unchanged, while FFA increased up to 70% of the lipid
extract. In this case, FFAweremostly composed of LA (77%),
whereas CLA altogether accounted for ca 4%.
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Table 3: Relative composition (%) of esterified and free fatty acids (EFAs and FFAs, resp.) in the biomass ofB. breveWC0421 at the exponential
and the stationary phase in MRS and MRS-LA.
MRS MRS-LA
Exponential Stationary Exponential Stationary
EFA
EFA/total FA 93a 92a 26b 25b
C10 0.8a 1.7b 1.2a 1.7b
C12 2.8a 4.2b 3.9b 4.2b
C14 8.6a 16.6b 13.7b 15.7b
C16 17.4 21.5 18.9 22
C16:1 1.1 1.9 1.9 2
C17 0.9 0.5 0 0.4
C18 4.2a 3.1a 0.0b 1.7b
C18:1 55.8a 41.3b 50.9a 43.9b
C18:2 LA 2.1 3.2 3.7 3.1
C18:2 9cis,11trans-CLA 1.6 1.2 0.9 1
C18:2 9trans,11trans-CLA 3.6 3.9 5 4
C20 0.3 0.3 0 0.1
C22 0.8 0.5 0 0.4
FFA
FFA/total FA 7a 8a 74b 75b
C10 0 0 0 0
C12 0 0 0 0
C14 3.2a 12.7b 1.2a 0.6a
C16 23.6a 22.0a 5.7b 2.4b
C16:1 0 0 0 0
C17 3.1a 1.6a 0.6b 0.3b
C18 10.4a 6.8a 2.5b 1.2b
C18:1 47.0a 46.2a 13.9b 8.3b
C18:2 LA 0.0a 0.0a 1.7b 2.8b
C18:2 9cis,11trans-CLA 2.1a 2.7a 58.6b 56.6b
C18:2 9trans,11trans-CLA 3.3a 7.1a 15.2b 27.0c
C20 4 0.9 0.2 0.4
C22 3.2 0 0.5 0.3
Values are means, 𝑛 = 3; SD always < 5%. Means in a row with different superscripts significantly differ (𝑃 < 0.05).
4. Discussion
The present study aims to gain further insight into CLA
production by bifidobacteria, since the capability of certain
strains to convert LA into CLA could find application in the
development of specific probiotic strains able to accelerate or
improve in vivo conversion of LA into CLA.
In vivo studies supporting biological activity of CLA
were initially performed using a mixture of CLA isomers,
while purified isomers have been used more recently, sup-
porting the evidence that different isomers have distinct
effect on the major health targets, such as tumorigenesis
and lipid metabolism [1]. However, most of commercial
formulations of CLA still contain both major isomers, whose
biological activity is mediated by diverse signaling path-
ways. 9cis,11trans-CLA isomer exerts an enhancing effect
on the nuclear transmission of PPAR𝛾, a master regula-
tor of adipocyte differentiation, acting as a stimulator of
adiponectin secretion [17]. This mechanism can to some
extent explain the antihypertensive, antihyperlipidemic,
antiarteriosclerotic, anticarcinogenic, and antidiabetic effects
mediated by this CLA [18]. Conversely, trans10,cis12-CLA
increases lipolysis and has the function of diminishing the
synthesis of fatty acids [19] but also presents a linkage with
proatherogenic effects, insulin resistance, and inflammation
[20].
The perspective to exploit specifically selected probiotic
bifidobacteria to produce a definite CLA isomer, such as
the 9cis,11trans-CLA, is quite attractive. The data herein
presented demonstrate that selected strains of bifidobacteria
specifically convert linoleic acid (LA) into 9cis,11trans-CLA
isomer, whereas 10trans,12cis-CLA, forwhich potential harm-
ful biological activities are still debated, is not produced by the
tested strains.
The screening of CLA production among the major
species of bifidobacteria demonstrated that the most effi-
cient CLA producers belong to the species B. breve and B.
pseudocatenulatum. Consistently, B. breve strains have been
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previously identified among the best CLAproducers, whereas
low or negligible activity was found in the strains belonging
to B. adolescentis, B. angulatum, B. bifidum, and B. infantis
[2, 9, 21]. Unlike previous studies that indicated B. pseudo-
catenulatum as almost incapable of LA transformation [2],
our data revealed that some strains of B. pseudocatenulatum
can efficiently accomplish the isomerization of LA.
The data herein presented are in agreement with observa-
tions by O’Connell et al. [9], which excluded that the product
of MCRA gene is involved in LA isomerization to CLA. In
the present study, all the best producers of CLA, belonging to
the species B. breve and B. pseudocatenulatum, were positive
to this gene, yet no hydroxylated forms of LA were detected
in their supernatants or in the biomass of B. breve WC
0421. A further clue hinting that MCRA is not involved in
CLA production is the fact that both MCRA-targeted PCR
and BLAST search for the gene revealed the presence of a
homologue in CLA producer and nonproducer species.
B. breve WC 0421 emerged as the most promising
strain for production of 9cis,11trans-CLA isomer. Our results
associate the production of cis9,trans11-CLA to the lag and
early growth phases, whereas supplementation of LA into
stationary phases resulted in negligible production of CLA.
This result supports the hypothesis that transformation of LA
in CLA can be a strategy of bacteria to detoxify unsaturated
fatty acid that interfere with membrane lipids. These in vitro
experiments have been carried out in batch, with a pure
culture, on a rich medium, with condition very different
from the intestinal ecosystem, where bifidobacteria represent
only a few percent of a complex mixed population. However,
bioproduction of CLA by supplemental probiotic bifidobac-
teria has been previously demonstrated [10]. For this reason,
B. breve WC 0421 may represent a promising candidate for
in vivo production of the specific health-promoting CLA
isomer.
The attention of the scientific community has been
focused on CLA production and absorption in the gastroin-
testinal tract. The analysis of fatty acid profile of biomass
associated lipids revealed that when B. breve WC 0421 was
cultured in presence of LA it accumulated CLA in the form
of free fatty acids, without changing the composition of
its esterified fatty acids, mainly occurring in the plasmatic
membrane.
5. Conclusions
Bifidobacteria are one of the most relevant health-promoting
indigenous species of the human gut microbiota, exerting
beneficial positive effects through a variety of different
mechanisms. Our study strengthened the perspectives on a
more specific use of probiotics, where the intrinsic health-
promoting properties of bifidobacteria can be associated with
peculiar features, such as producing in vivo health-promoting
CLA. Based on the current knowledge [2, 9, 21] and on the
outcome of this study, selected strains of Bifidobacterium,
mostly belonging to the species B. breve, can be exploited as
probiotics for in vivo production of 9cis,11trans-CLA.
The assessment of production and incorporation of CLA
in bifidobacterial biomass is a relevant result of our study.
Since the host-bacteria interaction is mediated by several
surface compounds, it is necessary to investigate the loca-
tion of 9cis,11trans-CLA within bifidobacterial cells and to
examine whether CLA enriched bifidobacteria exert a diverse
biological effect than the corresponding CLA-free cells.
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